Costs and reimbursement gaps after implementation of third-generation left ventricular assist devices

Journal of Heart and Lung Transplantation

Volumn 29, Issue 1, 2010, Pages 72-78

  Mishra, Vinod ^a,b   Geiran, Odd ^a   Fiane, Arnt E ^a   Sørensen, Gro ^a   Andresen, Sølvi ^a   Olsen, Ellen K ^a   Khushi, Ishtiaq ^a   Hagen, Terje P ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

cost analysis; DRG reimbursement; hospital cost; innovative technology; left ventricle assist device

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; BLOOD CHEMISTRY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DEVICE; EMBOLISM; EXTRACORPOREAL OXYGENATION; FEMALE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HEART TRANSPLANTATION; HOSPITAL CARE; HOSPITAL COST; HUMAN; IMPLANTATION; INFECTION; INTENSIVE CARE UNIT; LEFT VENTRICULAR ASSIST DEVICE; LENGTH OF STAY; MALE; MICROBIOLOGY; NORWAY; OPERATING ROOM; PRIORITY JOURNAL; PROSPECTIVE STUDY; REIMBURSEMENT; SEPSIS; UNITED STATES;

ADOLESCENT; ADULT; AGED; COST OF ILLNESS; COSTS AND COST ANALYSIS; DIAGNOSIS-RELATED GROUPS; FEMALE; HEART-ASSIST DEVICES; HOSPITAL COSTS; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; LENGTH OF STAY; MALE; MIDDLE AGED; NORWAY; RETROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 72249084152     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.06.029     Document Type: Article

References (18)

1. Pamboukian S.V., Costanzo M.R., Dunlap S., et al. Relationship between bridging with ventricular assist device on rejection after heart transplantation. J Heart Lung Transplant 24 (2005) 310-315
2. Massad M.G., and McCarthy P.M. Will permanent LVADs be better than heart transplantation?. Eur J Cardiothorac Surg 11 (1997) 11-17
3. Matsumiya G., Nishimura M., Miyamoto Y., et al. Successful treatment of Novacor pump pocket infection by omental transposition. Ann Thorac Surg 75 (2003) 287-288
4. Boucek M.M., Aurora P., Edwards L.B., et al. Registry of the International Society for Heart and Lung Transplantation: tenth official pediatric lung and heart/lung transplantation report-2007. J Heart Lung Transplant 26 (2007) 796-807
5. Esmore D., Kaye D., Spratt P., et al. A prospective, multicenter trial of the VentrAssist left ventricular assist device for bridge to transplant: safety and efficacy. J Heart Lung Transplant 27 (2008) 579-588
6. Sharples L.D., Dyer M., Cafferty F., et al. Cost-effectiveness of ventricular assist device use in United Kingdom: results from the Evaluation of Ventricular Assist Device Programme in the UK (EVAD-UK). J Heart Lung Transplant 25 (2006) 1336-1343
7. Girling A.J., Freeman G., Gordon J.P., et al. Modeling payback from research into the efficacy of left-ventricular assist devices as destination therapy. Int J Technol Assess Health Care 23 (2007) 269-277
8. Barnett P.G. Determination of VA health care costs. Med Care Res Rev 60 suppl (2003) 124S-141S
9. Mishra V., Skeie B., Vaaler S., et al. A comparison of actual registered costs and costs derived from diagnosis-related groups (DRGs) for patients undergoing heart transplantation, lung transplantation, and thoracotomy for other lung diseases. Transplant Int 14 (2001) 361-369
10. Classification of surgical procedures, clinical procedure code system guidelines (1999), Nordic Medico Statistical Committee (NOMESCO), Trondheim, Norway xiii-xxiii
11. Nordic Centre for Classifications in Health Care. Uppsala, Sweden, Nord DRG 2005 NOR Classic (Norway).
12. International classification of diseases, 10th revision. Norwegian version (2005), Oslo Ministry of Health and Care Services/World Health Organization, Oslo 1448-1482
13. Digiorgi P.L., Reel M.S., Thornton B., et al. Heart transplant and left ventricular assist device costs. J Heart Lung Transplant 24 (2005) 200-204
14. Esmore D.S., Kaye D., Salamonsen R., et al. First clinical implant of the VentrAssist left ventricular assist system as destination therapy for end-stage heart failure. J Heart Lung Transplant 24 (2005) 1150-1154
15. Moskowitz A.J., Rose E.A., and Gelijns A.C. The cost of long-term LVAD implantation. Ann Thorac Surg 71 suppl (2001) S195-S198
16. Miller L.W., Nelson K.E., Bostic R.R., et al. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era. J Heart Lung Transplant 25 (2006) 778-784
17. Clegg A.J., Scott D.A., Loveman E., et al. Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for people with end-stage heart failure: a systematic review and economic evaluation. Int J Technol Assess Health Care 23 (2007) 261-268
18. Hutchinson J., Scott D.A., Clegg A.J., et al. Cost-effectiveness of left ventricular-assist devices in end-stage heart failure. Expert Rev Cardiovasc Ther 6 (2008) 175-185